Literature DB >> 25348621

Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques.

Tsuyoshi Fujita1, Benjamin J Burwitz2, Glen M Chew3, Jason S Reed2, Reesab Pathak2, Elizabeth Seger2, Kiera L Clayton4, James M Rini4, Mario A Ostrowski4, Naoto Ishii5, Marcelo J Kuroda6, Scott G Hansen2, Jonah B Sacha7, Lishomwa C Ndhlovu8.   

Abstract

The T cell Ig- and mucin domain-containing molecule-3 (Tim-3) negative immune checkpoint receptor demarcates functionally exhausted CD8(+) T cells arising from chronic stimulation in viral infections like HIV. Tim-3 blockade leads to improved antiviral CD8(+) T cell responses in vitro and, therefore, represents a novel intervention strategy to restore T cell function in vivo and protect from disease progression. However, the Tim-3 pathway in the physiologically relevant rhesus macaque SIV model of AIDS remains uncharacterized. We report that Tim-3(+)CD8(+) T cell frequencies are significantly increased in lymph nodes, but not in peripheral blood, in SIV-infected animals. Tim-3(+)PD-1(+)CD8(+) T cells are similarly increased during SIV infection and positively correlate with SIV plasma viremia. Tim-3 expression was found primarily on effector memory CD8(+) T cells in all tissues examined. Tim-3(+)CD8(+) T cells have lower Ki-67 content and minimal cytokine responses to SIV compared with Tim-3(-)CD8(+) T cells. During acute-phase SIV replication, Tim-3 expression peaked on SIV-specific CD8(+) T cells by 2 wk postinfection and then rapidly diminished, irrespective of mutational escape of cognate Ag, suggesting non-TCR-driven mechanisms for Tim-3 expression. Thus, rhesus Tim-3 in SIV infection partially mimics human Tim-3 in HIV infection and may serve as a novel model for targeted studies focused on rejuvenating HIV-specific CD8(+) T cell responses.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25348621      PMCID: PMC4239185          DOI: 10.4049/jimmunol.1400961

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?

Authors:  Thorsten U Vogel; Thomas C Friedrich; David H O'Connor; William Rehrauer; Elizabeth J Dodds; Heather Hickman; William Hildebrand; John Sidney; Alessandro Sette; Austin Hughes; Helen Horton; Kathy Vielhuber; Richard Rudersdorf; Ivna P De Souza; Matthew R Reynolds; Todd M Allen; Nancy Wilson; David I Watkins
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 2.  HIV and SIV CTL escape: implications for vaccine design.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

3.  Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.

Authors:  Bianca R Mothé; Helen Horton; Donald K Carter; Todd M Allen; Max E Liebl; Pam Skinner; Thorsten U Vogel; Sarah Fuenger; Kathy Vielhuber; William Rehrauer; Nancy Wilson; Genoveffa Franchini; John D Altman; Ashley Haase; Louis J Picker; David B Allison; David I Watkins
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.

Authors:  T Matano; R Shibata; C Siemon; M Connors; H C Lane; M A Martin
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

6.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  In vivo migration and function of transferred HIV-1-specific cytotoxic T cells.

Authors:  S J Brodie; D A Lewinsohn; B K Patterson; D Jiyamapa; J Krieger; L Corey; P D Greenberg; S R Riddell
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

Review 8.  The TIM gene family: emerging roles in immunity and disease.

Authors:  Vijay K Kuchroo; Dale T Umetsu; Rosemarie H DeKruyff; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

9.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

Authors:  X Jin; D E Bauer; S E Tuttleton; S Lewin; A Gettie; J Blanchard; C E Irwin; J T Safrit; J Mittler; L Weinberger; L G Kostrikis; L Zhang; A S Perelson; D D Ho
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

View more
  16 in total

1.  Accumulation of Cytotoxic CD16+ NK Cells in Simian Immunodeficiency Virus-Infected Lymph Nodes Associated with In Situ Differentiation and Functional Anergy.

Authors:  Jamie L Schafer; Haiying Li; Tristan I Evans; Jacob D Estes; R Keith Reeves
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

Review 2.  Impact of Myeloid Reservoirs in HIV Cure Trials.

Authors:  Brooks I Mitchell; Elizabeth I Laws; Lishomwa C Ndhlovu
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

3.  Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.

Authors:  Mauricio A Martins; Damien C Tully; Michael A Cruz; Karen A Power; Marlon G Veloso de Santana; David J Bean; Colin B Ogilvie; Rujuta Gadgil; Noemia S Lima; Diogo M Magnani; Keisuke Ejima; David B Allison; Michael Piatak; John D Altman; Christopher L Parks; Eva G Rakasz; Saverio Capuano; Ricardo Galler; Myrna C Bonaldo; Jeffrey D Lifson; Todd M Allen; David I Watkins
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

Review 4.  T cell exhaustion during persistent viral infections.

Authors:  Shannon M Kahan; E John Wherry; Allan J Zajac
Journal:  Virology       Date:  2015-01-22       Impact factor: 3.616

5.  Up-regulation of Tim-3 on T cells during acute simian immunodeficiency virus infection and on antigen specific responders.

Authors:  Praveen K Amancha; Jung Joo Hong; Aftab A Ansari; Francois Villinger
Journal:  AIDS       Date:  2015-03-13       Impact factor: 4.177

Review 6.  Strategies to target non-T-cell HIV reservoirs.

Authors:  Jonah B Sacha; Lishomwa C Ndhlovu
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

7.  Oncogenic role of Tc17 cells in cervical cancer development.

Authors:  Zun-Sheng Zhang; Ying Gu; Bing-Gang Liu; Hong Tang; Yu Hua; Jun Wang
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

Review 8.  Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer.

Authors:  Isobel S Okoye; Michael Houghton; Lorne Tyrrell; Khaled Barakat; Shokrollah Elahi
Journal:  Front Immunol       Date:  2017-09-29       Impact factor: 7.561

9.  Upregulation of Multiple CD8+ T Cell Exhaustion Pathways Is Associated with Recurrent Ocular Herpes Simplex Virus Type 1 Infection.

Authors:  Pierre-Grégoire Coulon; Soumyabrata Roy; Swayam Prakash; Ruchi Srivastava; Nisha Dhanushkodi; Stephanie Salazar; Cassandra Amezquita; Lan Nguyen; Hawa Vahed; Angela M Nguyen; Wasay R Warsi; Caitlin Ye; Edgar A Carlos-Cruz; Uyen T Mai; Lbachir BenMohamed
Journal:  J Immunol       Date:  2020-06-15       Impact factor: 5.426

10.  TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.

Authors:  Glen M Chew; Tsuyoshi Fujita; Gabriela M Webb; Benjamin J Burwitz; Helen L Wu; Jason S Reed; Katherine B Hammond; Kiera L Clayton; Naoto Ishii; Mohamed Abdel-Mohsen; Teri Liegler; Brooks I Mitchell; Frederick M Hecht; Mario Ostrowski; Cecilia M Shikuma; Scott G Hansen; Mark Maurer; Alan J Korman; Steven G Deeks; Jonah B Sacha; Lishomwa C Ndhlovu
Journal:  PLoS Pathog       Date:  2016-01-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.